A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1999
12/28/1999	US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999	US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999	US6008042 A polynucleotide; diagnosis and therapy for stroke, septic shock, acquired immune deficiency syndrome, osteoporosis, antiarthritic/antiinflammatory/antiischemic agents, genetic disorders; alzheimer's/parkinson's diseases
12/28/1999	US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999	US6008035 System for the in vivo delivery and expression of heterologous genes in the bone marrow
12/28/1999	US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999	US6008022 Human cytokine polypeptide
12/28/1999	US6008017 Human cardiac/brain tolloid-like protein
12/28/1999	US6007995 Antisense inhibition of TNFR1 expression
12/28/1999	US6007988 A library of dna sequences which encode zinc finger polypeptide binding motifs for display on viral particles; the dna sequences having random allocation of amino acids; for producing zinc finger molecules
12/28/1999	US6007806 Vaccinia virus vector comprising a heterologous dna sequence coding for essential region of t antigen, a protein specific to tumors caused by a papilloma virus
12/23/1999	WO1999066072A2 Methods for treating a neurological disease by determining bche genotype
12/23/1999	WO1999066065A2 Proteasomal activity
12/23/1999	WO1999066061A1 Nucleic acid transfer phage
12/23/1999	WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999	WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	WO1999066045A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999	WO1999066041A1 94 human secreted proteins
12/23/1999	WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999	WO1999066036A1 Transplants for myocardial scars
12/23/1999	WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999	WO1999065937A2 Truncated apaf-1 and methods of use thereof
12/23/1999	WO1999065531A1 Polymers for delivery of nucleic acids
12/23/1999	WO1999065530A1 NrdD
12/23/1999	WO1999065529A1 Nucleic acid-cobalamin complexes and their use in gene therapy
12/23/1999	WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999	WO1999065461A2 Cationic amphiphile micellar complexes
12/23/1999	WO1999055728A3 Ese genes and proteins
12/23/1999	WO1999054493A3 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
12/23/1999	WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999	WO1999051629A3 New compounds for dna-transfection
12/23/1999	WO1999047558A3 T cell costimulatory proteins, sequences and uses thereof
12/23/1999	WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999	WO1999041364A3 Compositions and methods for wound healing
12/23/1999	WO1999040212A3 Bacteriophage vectors generated by bacteriophage/plasmid recombination
12/23/1999	DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999	DE19812375C1 Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände For nucleic acid coding for tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, to antibodies against tumor suppressor proteins and use of these articles
12/23/1999	CA2335638A1 Cationic amphiphile micellar complexes
12/23/1999	CA2335460A1 Polymers for delivery of nucleic acids
12/23/1999	CA2335248A1 Transplants for myocardial scars
12/23/1999	CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999	CA2334165A1 Newcastle disease virus infectious clones, vaccines and diagnostic assays
12/23/1999	CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999	CA2331384A1 Nucleic acid transfer phage
12/23/1999	CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999	CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999	CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999	CA2330842A1 Truncated apaf-1 and methods of use thereof
12/23/1999	CA2330210A1 Proteasomal activity
12/22/1999	EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999	EP0965639A1 Attenuated pestiviruses
12/22/1999	EP0965584A2 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999	EP0965583A1 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999	EP0965336A1 Microencapsulated DNA for gene therapy
12/22/1999	EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999	EP0964922A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/22/1999	EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999	EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999	EP0964704A1 Methods and compositions for nucleic acid targeting
12/22/1999	EP0964697A1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
12/22/1999	EP0964694A1 Mucin-mediated immunomodulation
12/22/1999	EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999	CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/21/1999	US6005095 Antisense agents; antitumor agents
12/21/1999	US6005087 Nuclease resistant oligonucleotides which are useful as therapeutics, diagnostics, and research reagents for various viral diseases
12/21/1999	US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999	US6005074 Cloning of human GPR14 receptor
12/21/1999	US6005002 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production
12/21/1999	US6004944 Protein delivery by secretory gland expression
12/21/1999	US6004943 Protein-coated medical substrates for local delivery of genes and method of forming coatings on the substrates
12/21/1999	US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999	US6004941 Introducing nucleic acid encoding fusion protein which activates transcription and comprises a polypeptide that binds to tetracycline operator
12/21/1999	US6004813 Il-6 activity inhibitor
12/21/1999	US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999	US6004797 Adenovirus helper-free recombinant AAV Virion production
12/21/1999	US6004794 Human serine protease
12/21/1999	US6004780 Growth factor HTTER36
12/21/1999	US6004777 Vectors having enhanced expression, and methods of making and uses thereof
12/21/1999	US6004759 Methods and compositions for diagnosing autoimmune insulin dependant diabetes mellitus
12/21/1999	US6004556 Staphylococcus aureus RSBU-1
12/21/1999	US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999	US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system
12/21/1999	CA2197075C Method of gene therapy using dna vectors without selection marker gene
12/17/1999	CA2235420A1 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/16/1999	WO1999064631A1 Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
12/16/1999	WO1999064629A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein)
12/16/1999	WO1999064628A1 Detection of dna, rna and proteins
12/16/1999	WO1999064615A1 Formulations for electroporation
12/16/1999	WO1999064606A1 Tankyrase, a trfi binding protein
12/16/1999	WO1999064604A2 Attenuated pestiviruses
12/16/1999	WO1999064589A1 Human receptor tyrosine kinase
12/16/1999	WO1999064588A1 TGFβ RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES
12/16/1999	WO1999064585A2 Novel angiotensin receptor, production and use thereof
12/16/1999	WO1999064582A2 High-throughput screening of gene function using libraries for functional genomics applications
12/16/1999	WO1999064577A1 Novel adenoviral vectors for gene therapy
12/16/1999	WO1999064572A2 Poly(adp-ribose) polymerase gene
12/16/1999	WO1999064566A2 In vitro maintenance of hematopoietic stem cells
12/16/1999	WO1999064565A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells

1 ... 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 ... 870